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Introduction: The pain of acute herpes zoster (shingles) is severe and difficult to control. The medications used to
control pain have a variety of important and potentially serious side effects. To the best of my knowledge, this is
the first case report of using a plain topical occlusive dressing to reduce the pain of herpes zoster, avoiding the use
of medication.
Case presentation: A 40-year-old Caucasian man and a qualified physician (the author), developed a dermatomal
vesicular rash consistent with herpes zoster. Applying plain topical occlusive dressings reduced the severity of his
pain to an ignorable level.
Conclusion: Plain topical occlusive dressings provide effective pain relief for acute herpes zoster, thereby avoiding
the risks accompanying medication use.Introduction
I describe the case of a patient (the author) with acute
herpes zoster (shingles), treated using a plain topical oc-
clusive dressing to reduce the pain, thereby avoiding the
use of medication. The lifetime risk of acquiring herpes
zoster (for unvaccinated individuals) has been estimated
to be 32% for women and 22% for men [1]. The acute
pain of herpes zoster can be debilitating [2], and satisfac-
tory pain control is difficult to achieve [2]. Patients can
have a varied pain presentation including severe pain,
hypersensitivity, and allodynia (pain in response to nor-
mally non-painful stimuli) [3]. Currently recommended
therapies for acute severe pain include non-steroidal
anti-inflammatories, narcotics, prednisone, and gabapen-
tin [2], all of which carry risks of a variety of severe side
effects and complications.
Some studies have evaluated the use of topical anal-
gesia for the acute pain of herpes zoster. One uncon-
trolled study of lidocaine in petroleum jelly suggested a
role for this therapy, but noted there were a large num-
ber of practical factors in applying the dressings and
keeping them on that limited its usefulness [4]. Another
study was a blinded comparison between patients who
received aqueous patches containing lidocaine and otherCorrespondence: dkeegan@ucalgary.ca
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study, while there was some pain score improvement in
the patients who received the plain aqueous patches,
there was a more substantial improvement in those who
received the lidocaine aqueous patches [5].Case presentation
The author, a 40-year-old Caucasian man and a qualified
physician, developed a ‘barbed-wire-like’ painful left lat-
eral thigh vesicular eruption in a dermatomal pattern.
The rash had been preceded by two days of ‘electric,
aching’ pain without skin changes at the same site, and
occurred during a period of significantly reduced sleep
due to an unexpected death of a sibling. The suspected
diagnosis of herpes zoster was confirmed within four
hours of the vesicle eruption, at an urgent care centre,
and a seven-day course of oral valacyclovir 1000mg, ad-
ministered orally three times a day (GlaxoSmithKline,
Mississauga, Canada), was started immediately, along
with naproxen (Bayer Inc., Mississauga, Canada) and
oral codeine (Ratiopharm, Toronto, Canada) for analgesia.
The codeine and naproxen had minimal impact on the
severity of his pain, which was constantly present. His
pain was further aggravated by any contact with the
affected skin, including contact by clothing. Altogether,
this pain constellation led to poor sleep, difficulty inis an Open Access article distributed under the terms of the Creative Commons
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stressful period.
In an effort to avoid increased narcotic use or add-
itional medications (and their possible side effects), he
elected to apply a series of plain occlusive dressings
(Tegaderm™; 3M, London, Canada) directly over the ves-
icular eruption, as depicted in Figure 1. This decision
was based upon a spontaneous hypothesis that an add-
itional layer of skin (albeit artificial) might reduce the
severity of his constant pain and skin hypersensitivity.
His pain reduced immediately to a tolerable (and ig-
norable) level, from approximately eight out of 10 (with
codeine and naproxen) to four out of 10 on a numerical
pain scale (with 0 being no pain and 10 being severe
pain). More importantly, incidental contact by clothes
and water in the shower no longer resulted in additional
severe lancing pain. Subsequent to the occlusive dressing
application, no more analgesics were taken, and his pain
level never increased above four out of 10 on the numer-
ical pain scale. The occlusive dressings were applied for
the duration of the vesicles, being finally removed after
eight days. Peeling dressings were removed and replaced
during this period. The removal of partially peeling
dressings resulted in mild worsened pain at the time of
removal, akin to removing a regular adhesive bandage. If
replacement was delayed for longer than five minutes,
his previous severe level of pain would begin to return,
and promptly returned to four out of 10 or lower with
subsequent reapplication. Full resolution of his symp-
toms occurred over approximately two and a half weeks,
with no post-herpetic neuralgia.Figure 1 Depiction of occlusive dressings over vesicular lesions. Alteration
photograph accessible at http://commons.wikimedia.org/wiki/File:Shingles_Discussion
The intervention described here is an attractive option
as it removed the need for oral analgesia for the constant
pain and hypersensitivity caused by herpes zoster. As a
result, all potential side effects and potential drug inter-
actions of oral medications were avoided. The occlusive
dressing reduced his constant pain by half and greatly
limited his hypersensitivity, bringing it to a tolerable
level, allowing resumption of regular activities. It is pos-
sible that these occlusive dressings may work for other
pain variants of acute herpes zoster, though this should
be studied.
It has been previously proposed that herpes simplex
virus (HSV) lesions may be treated with plain occlusive
dressings, based upon a histological analysis that sug-
gested HSV skin injury is similar to partial-thickness skin
wounds [6]. The same rationale has been used, by exten-
sion, to support occlusive dressing use in the care of
herpes zoster eruptions [7].
A PubMed search did not reveal any clinical thera-
peutic studies of any type evaluating the use of plain
occlusive dressings for analgesia in this condition. How-
ever, in a blinded control study by Lin et al. [5], the
control arm was an aqueous (non-active) patch. The
substantial pain relief by the plain Tegaderm™ in this
case report was more in keeping with the better pain re-
lief experienced by patients in the aqueous lidocaine arm
of the study by Lin et al. [5]. It is possible that while the
patch itself protected the skin, the aqueous base aggra-
vated the inflamed skin, thereby limiting the potential
benefit of the physical barrier of the patch. More studyof Creative Commons Licensed work by Preston Hunt; original
on_the_chest.jpg.
Keegan Journal of Medical Case Reports  (2015) 9:89 Page 3 of 3needs to be done to see if the thin, plain Tegaderm™
dressings are equal in analgesia to lidocaine aqueous
patches.
A reasonable clinical management approach might be
to recommend plain Tegaderm™ use (as was done here)
and ensure patients have multiple spare dressings, so
as to allow removal and reapplication when applied
dressings become problematic (as a result of peeling,
bunching, or water interposition). The potential reduc-
tion in acute pain severity this option provides (without
the complications of traditional analgesia) to patients
with herpes zoster is large, given the difficulty in achiev-
ing satisfactory pain control with usual therapy.
Conclusion
Plain occlusive dressings may provide effective analgesia
for acute herpes zoster, thereby avoiding the risks
accompanying medication use.
Patient perspective
Herpes zoster was most unwelcome in the days immedi-
ately following my sister’s unexpected death. It was a
great relief that I had an instant reduction of pain after
applying the Tegaderm™ dressings, as it meant I could
then focus on the needs of my family and issues related
to her estate. It was months later that I fully realized this
was an important clinical finding to share.
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